Veracyte Capital Stock from 2010 to 2024

VCYT Stock

USD 42.89 0.05 0.12%

Veracyte Capital Stock yearly trend continues to be comparatively stable with very little volatility. Capital Stock will likely drop to about 66.9 K in 2024. Capital Stock is the total amount of a company's capital funded by shareholders through the issue and subscription of shares. View All Fundamentals

Capital Stock

First Reported

2010-12-31

Previous Quarter

73 K

Current Value

66.9 K

Quarterly Volatility

13.4 K

Credit Downgrade

Yuan Drop

Covid

Check Veracyte financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Veracyte's main balance sheet or income statement drivers, such as Depreciation And Amortization of 28.5 M, Interest Expense of 14.2 K or Selling General Administrative of 165.5 M, as well as many indicators such as Price To Sales Ratio of 5.26, Dividend Yield of 0.0 or PTB Ratio of 1.82. Veracyte financial statements analysis is a perfect complement when working with Veracyte Valuation or Volatility modules.

Check out the analysis of Veracyte Correlation against competitors.

For more information on how to buy Veracyte Stock please use our How to Invest in Veracyte guide.

Latest Veracyte's Capital Stock Growth Pattern

Below is the plot of the Capital Stock of Veracyte over the last few years. It is the total amount of a company's capital funded by shareholders through the issue and subscription of shares. Veracyte's Capital Stock historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Veracyte's overall financial position and show how it may be relating to other accounts over time.

Capital Stock

10 Years Trend

Slightly volatile

Compare to Others All Fundamentals

Capital Stock

Timeline

Veracyte Capital Stock Regression Statistics

	Arithmetic Mean	50,661
	Geometric Mean	49,165
	Coefficient Of Variation	26.52
	Mean Deviation	11,681
	Median	41,000
	Standard Deviation	13,434
	Sample Variance	180.5M
	Range	32K
	R-Value	0.85
	Mean Square Error	53M
	R-Squared	0.73
	Significance	0.000053
	Slope	2,562
	Total Sum of Squares	2.5B

Veracyte Capital Stock History

	2024	66.9 K
	2023	73 K
	2022	72 K
	2021	71 K
	2020	58 K
	2019	50 K

Other Fundumenentals of Veracyte

Issuance Of Capital Stock

Veracyte Capital Stock component correlations

	Total Assets	Total Stockholder Equity	Net Debt	Retained Earnings	Accounts Payable	Net Receivables	Total Liab	Total Current Assets	Common Stock	Property Plant Equipment	Short Term Investments	Net Tangible Assets	Long Term Debt	Good Will	Long Term Debt Total	Capital Surpluse	Deferred Long Term Liab	Intangible Assets	Short Long Term Debt	Short Term Debt	Net Invested Capital	Net Working Capital	Capital Stock	Current Deferred Revenue
Total Assets		1.0	-0.68	-0.88	0.9	0.97	0.84	0.73	0.81	0.96	0.47	0.87	-0.47	0.97	-0.47	0.99	0.58	0.87	-0.41	0.0	0.79	0.69	0.98	0.9
Total Stockholder Equity	1.0		-0.68	-0.87	0.9	0.97	0.83	0.73	0.8	0.96	0.47	0.87	-0.48	0.97	-0.48	0.99	0.57	0.87	-0.43	-0.02	0.79	0.69	0.98	0.9
Net Debt	-0.68	-0.68		0.69	-0.48	-0.67	-0.52	-0.94	-0.74	-0.56	-0.27	-0.85	0.5	-0.5	0.5	-0.68	-0.7	-0.56	0.47	0.23	-0.61	-0.98	-0.75	-0.42
Retained Earnings	-0.88	-0.87	0.69		-0.75	-0.94	-0.82	-0.75	-0.87	-0.91	-0.4	-0.83	0.19	-0.81	0.19	-0.9	-0.71	-0.73	0.24	-0.13	-0.77	-0.73	-0.87	-0.69
Accounts Payable	0.9	0.9	-0.48	-0.75		0.85	0.78	0.52	0.7	0.91	0.34	0.72	-0.41	0.93	-0.41	0.89	0.31	0.74	-0.34	0.05	0.71	0.45	0.85	0.84
Net Receivables	0.97	0.97	-0.67	-0.94	0.85		0.89	0.75	0.87	0.96	0.51	0.85	-0.33	0.93	-0.33	0.97	0.67	0.87	-0.33	0.07	0.78	0.7	0.96	0.85
Total Liab	0.84	0.83	-0.52	-0.82	0.78	0.89		0.71	0.92	0.84	0.54	0.59	-0.1	0.8	-0.1	0.8	0.66	0.89	-0.13	0.24	0.51	0.54	0.83	0.81
Total Current Assets	0.73	0.73	-0.94	-0.75	0.52	0.75	0.71		0.88	0.62	0.44	0.81	-0.41	0.56	-0.41	0.71	0.78	0.72	-0.4	-0.12	0.59	0.96	0.81	0.51
Common Stock	0.81	0.8	-0.74	-0.87	0.7	0.87	0.92	0.88		0.78	0.52	0.72	-0.19	0.69	-0.19	0.78	0.79	0.82	-0.24	0.09	0.59	0.76	0.83	0.65
Property Plant Equipment	0.96	0.96	-0.56	-0.91	0.91	0.96	0.84	0.62	0.78		0.38	0.81	-0.3	0.96	-0.3	0.97	0.57	0.78	-0.26	0.15	0.79	0.57	0.92	0.85
Short Term Investments	0.47	0.47	-0.27	-0.4	0.34	0.51	0.54	0.44	0.52	0.38		0.41	-0.21	0.42	-0.21	0.4	0.27	0.65	-0.26	-0.1	0.47	0.35	0.5	0.38
Net Tangible Assets	0.87	0.87	-0.85	-0.83	0.72	0.85	0.59	0.81	0.72	0.81	0.41		-0.53	0.79	-0.53	0.9	0.57	0.63	-0.48	-0.14	0.92	0.86	0.9	0.58
Long Term Debt	-0.47	-0.48	0.5	0.19	-0.41	-0.33	-0.1	-0.41	-0.19	-0.3	-0.21	-0.53		-0.43	1.0	-0.45	-0.12	-0.43	0.78	0.64	-0.4	-0.48	-0.53	-0.39
Good Will	0.97	0.97	-0.5	-0.81	0.93	0.93	0.8	0.56	0.69	0.96	0.42	0.79	-0.43		-0.43	0.97	0.44	0.82	-0.37	0.04	0.77	0.52	0.93	0.91
Long Term Debt Total	-0.47	-0.48	0.5	0.19	-0.41	-0.33	-0.1	-0.41	-0.19	-0.3	-0.21	-0.53	1.0	-0.43		-0.45	-0.12	-0.43	0.78	0.64	-0.4	-0.48	-0.53	-0.39
Capital Surpluse	0.99	0.99	-0.68	-0.9	0.89	0.97	0.8	0.71	0.78	0.97	0.4	0.9	-0.45	0.97	-0.45		0.58	0.8	-0.41	0.0	0.84	0.7	0.97	0.85
Deferred Long Term Liab	0.58	0.57	-0.7	-0.71	0.31	0.67	0.66	0.78	0.79	0.57	0.27	0.57	-0.12	0.44	-0.12	0.58		0.62	-0.1	0.13	0.37	0.72	0.63	0.45
Intangible Assets	0.87	0.87	-0.56	-0.73	0.74	0.87	0.89	0.72	0.82	0.78	0.65	0.63	-0.43	0.82	-0.43	0.8	0.62		-0.37	-0.03	0.49	0.61	0.88	0.89
Short Long Term Debt	-0.41	-0.43	0.47	0.24	-0.34	-0.33	-0.13	-0.4	-0.24	-0.26	-0.26	-0.48	0.78	-0.37	0.78	-0.41	-0.1	-0.37		0.91	-0.36	-0.48	-0.46	-0.34
Short Term Debt	0.0	-0.02	0.23	-0.13	0.05	0.07	0.24	-0.12	0.09	0.15	-0.1	-0.14	0.64	0.04	0.64	0.0	0.13	-0.03	0.91		-0.04	-0.23	-0.05	0.03
Net Invested Capital	0.79	0.79	-0.61	-0.77	0.71	0.78	0.51	0.59	0.59	0.79	0.47	0.92	-0.4	0.77	-0.4	0.84	0.37	0.49	-0.36	-0.04		0.62	0.79	0.46
Net Working Capital	0.69	0.69	-0.98	-0.73	0.45	0.7	0.54	0.96	0.76	0.57	0.35	0.86	-0.48	0.52	-0.48	0.7	0.72	0.61	-0.48	-0.23	0.62		0.78	0.44
Capital Stock	0.98	0.98	-0.75	-0.87	0.85	0.96	0.83	0.81	0.83	0.92	0.5	0.9	-0.53	0.93	-0.53	0.97	0.63	0.88	-0.46	-0.05	0.79	0.78		0.85
Current Deferred Revenue	0.9	0.9	-0.42	-0.69	0.84	0.85	0.81	0.51	0.65	0.85	0.38	0.58	-0.39	0.91	-0.39	0.85	0.45	0.89	-0.34	0.03	0.46	0.44	0.85

Click cells to compare fundamentals

About Veracyte Financial Statements

Veracyte shareholders use historical fundamental indicators, such as Capital Stock, to determine how well the company is positioned to perform in the future. Although Veracyte investors may analyze each financial statement separately, they are all interrelated. The changes in Veracyte's assets and liabilities, for example, are also reflected in the revenues and expenses on on Veracyte's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.

		Last Reported	Projected for Next Year
	Capital Stock	73 K	66.9 K

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for Veracyte Stock Analysis

When running Veracyte's price analysis, check to measure Veracyte's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Veracyte is operating at the current time. Most of Veracyte's value examination focuses on studying past and present price action to predict the probability of Veracyte's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Veracyte's price. Additionally, you may evaluate how the addition of Veracyte to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Veracyte Capital Stock from 2010 to 2024

Latest Veracyte's Capital Stock Growth Pattern

Veracyte Capital Stock Regression Statistics

Veracyte Capital Stock History

Other Fundumenentals of Veracyte

Veracyte Capital Stock component correlations

About Veracyte Financial Statements

Thematic Opportunities

Explore Investment Opportunities

Additional Tools for Veracyte Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY